A small molecule inhibitor of redox-regulated NF-κB and activator protein-1 transcription blocks allergic airway inflammation in a mouse asthma model

Journal of Immunology

Volumn 169, Issue 9, 2002, Pages 5294-5299

  Henderson Jr , William R ^a   Chi, Emil Y ^a   Teo, Jia Ling ^a   Nguyen, Cu ^a   Kahn, Michael ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METHYL 4 HYDROXY 4 (8 METHYL 1,2 DIOXO 2 PHENYL 2,3,5,8 TETRAHYDRO 1H [1,2,4]TRIAZOLO[1,2 A]PYRIDAZIN 5 YL) 2 BUTYNOATE; NEUROPEPTIDE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; CONTROLLED STUDY; EOSINOPHILIA; FEMALE; IMMUNOPATHOGENESIS; INFLAMMATION; MOUSE; MUCUS SECRETION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM;

EID: 0036839618     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.9.5294     Document Type: Article

References (54)

1. Kay, A. B. 1997. T cells as orchestrators of the asthmatic response. Ciba Found. Symp. 206:56.
2. Krug, N., J. Madden, A. E. Redington, P. Lackie, R. Djukanovic, U. Schauer, S. T. Holgate, A. J. Frew, and P. H. Howarth. 1996. T-cell cytokine profile evaluated at the single cell level in BAL and blood in allergic asthma. Am. J. Respir. Cell Mol. Biol. 14:319.
3. Cantin, A. M., S. L. North, R. C. Hubbard, and R. G. Crystal. 1987. Normal alveolar epithelial lining fluid contains high levels of glutathione. J. Appl. Physiol. 63:152.
4. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10:405.
5. Baeuerle, P. A., and D. Baltimore. 1996. NF-κB: Ten years after. Cell 87:13.
6. Baldwin, A. S., Jr. 1996. The NF-κB and IκB proteins: New discoveries and insights. Annu. Rev. Immunol. 14:649.
7. Gilmore, T. D. 1999. The Rel/NF-κB signal transduction pathway: Introduction. Oncogene 18:6842.
8. Hart, L. A., V. L. Krishnan, I. M. Adcock, P. J. Barnes, and K. F. Chung. 1998. Activation and localization of transcription factor, nuclear factor-κB, in asthma. Am. J. Respir. Crit. Care Med. 158:1585
9. Stutz, A. M., and M. Woisetschlager. 1999. Functional synergism of STAT6 with either NF-κB or PU.I to mediate IL-4-induced activation of IgE germline gene transcription. J. Immunol 163:4383.
10. Mori, A., O. Kaminuma, T. Mikami, S. Inoue. Y. Okumura, K. Akiyama, and H. Okudaira. 1999. Transcriptional control of the IL-5 gene by human helper T cells: IL-5 synthesis is regulated independently from IL-2 or IL-4 synthesis. J. Allergy Clin. Immunol. 103:429.
11. Barnes, P. J., and I. M. Adcock. 1997. NF-κB: A pivotal role in asthma and a new target for therapy. Trends Pharmacol. Sci. 18:46.
12. Zhu, Y. X., L. Y. Kang, W. Luo, C. C. H. Li, L. Yang, and Y. C. Yang. 1996. Multiple transcription factors are required for activation of human interleukin 9 gene in T cells. J. Biol. Chem. 271:15815.
13. Washizu, J., H. Nishimura, N. Nakamura, Y. Nimura, and Y. Yoshikai. 1998. The NF-κB binding site is essential for transcriptional activation of the IL-15 gene. Immunogenetics 48:1.
14. Christman, J. W., R. T. Sadikot, and T. S. Blackwell. 2000. The role of nuclear factor-κB in pulmonary diseases. Chest 117:1482.
15. Wulczyn, F. G., D. Krappmann, and C. Scheidereit. 1996. The NF-κB/Rel and I κB gene families: Mediators of immune response and inflammation. J. Mol. Med. 74:749.
16. Yang, L., L. Cohn, D. H. Zhang, R. Homer, A. Ray, and P. Ray, 1998. Essential role of nuclear factor κB in the induction of eosinophilia in allergic airway inflammation. J. Exp. Med. 188:1739.
17. Angel, P., and M. Karin. 1991. The role of Jun. Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072:129.
18. Lee, W., P. Mitchell, and R. Tjian. 1987. Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49:741.
19. 2O2. Free Radical Biol. Med. 24:632.
20. Singh, N., and S. Aggarwal. 1995. The effect of active oxygen generated by xanthine/xanthine oxidase on genes and signal transduction in mouse epidermal JB6 cells. Int. J. Cancer 62:107.
21. Ozolins, T. R., and B. F. Hales, 1997. Oxidative stress regulates the expression and activity of transcription factor activator protein-1 in rat conceptus. J. Pharmacol. Exp. Ther. 280:1085.
22. Nose, K., M. Shibanuma, K. Kikucbi, H. Kageyama, S. Sakiyama, and T. Kuroki. 1991. Transcriptional activation of early-response genes by hydrogen peroxide in a mouse osteoblastic cell line. Eur. J Biochem. 201:99.
23. Abate, C., L. Patel, F. J. Rauscher, and T. Curran. 1990. Redox regulation of fos and jun DNA-binding activity in vitro. Science 249:1157.
24. Schenk, H., M. Klein, W. Erdbrugger, W. Droge, and K. Schulze-Osthoff. 1994. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-κB and AP-1. Proc. Natl. Acad. Sci. USA 91:1672.
25. Dalton, T. P., H. G. Shertzer, and A. Puga. 1999. Regulation of gene expression by reactive oxygen. Annu. Rev. Pharmacol. Toxicol. 39:67.
26. Nakamura, H., K. Nakamura, and J. Yodoi. 1997. Redox regulation of cellular activation. Annu. Rev. Immunol. 15:351.
27. Van, S., I. M. Perrais, P. Pigny, N. Porchet, and J. P. Aubert. 2000. Sequence of the 5′-flanking region and promoter activity of the human mucin gene MUC5B in different phenotypes of colon cancer cells. Biochem. J. 3:675.
28. Song, Z., V. Casolaro, R. Chen, S. N. Georas, D. Monos, and S. J. Ono. 1996. Polymorphic nuclectides within the human IL-4 promoter that mediate overexpression of the gene. J. Immunol. 156:424.
29. Misra-Press, A., M. McMillan, E. Cudaback, M. Qabar, F. Ruan, M. Nguyen, T. Vaisar, H. Nakanishi, and M. Kahn. 2002. Identification of a novel inhibitor of the NF-κB pathway. Curr. Med. Chem. 1:29.
30. Boatman, P. D., C. O. Ogbu, M. Eguchi, H. O. Kim, H. Nakanishi, B. Cao, J. P. Shea, and M. Kahn. 1999. Secondary structure peptide mimetics: Design, synthesis, and evaluation of β-strand mimetic thrombin inhibitors. J. Med. Chem. 42:1367.
31. Slaby, I., V. Cerna, M. F. Jeng, H. J. Dyson, and A. Holmgren. 1996. Replacement of Trp28 in Escherichia coli thioredoxin by site-directed mutagenesis affects thermodynamic stability but not function. J. Biol. Chem. 271:3091.
32. Henderson, W. R., Jr., D. B. Lewis, R. K. Albert, Y. Zhang, W. J. E. Lamm, G. K. S. Chiang, F. Jones, P. Eriksen, Y. Tien, M. Jonas. and E. Y. Chi. 1996. The importance of leukotrienes in airway inflammation in a mouse model of asthma. J. Exp. Med. 184:1483.
33. Henderson, W. R., Jr., E. Y. Chi, and C. R. Maliszewski. 2000. Soluble IL-4 receptor inhibits airway inflammation following allergen challenge in a mouse model of asthma. J. Immunol. 164:1086.
34. Oh, S. W., I. P. Chong, L. Dong-Keun, F. Jones, G. K. S. Chiang, H. O. Kim. S.-H. Moon, B. Cao, C. Ogbu, K.-W. Jeong, et al. 2002. Tryptase inhibition blocks airway inflammation in a mouse asthma model. J. Immunol. 168:1992.
35. Millman, M., F. M. Millman, I. M. Goldstein, and A. J. Mercandetti. 1985. Use of acetylcysteine in bronchial asthma - Another look. Ann. Allergy 54:294.
36. Dorsch, W., E. Auch, and P. Powerlowicz. 1987. Adverse effects of acetylcysteine on human and guinea pig bronchial asthma in vivo and on human fibroblasts and leukocytes in vitro. Int. Arch. Allergy Immunol. 82.33.
37. Neuman, I., H. Nahum, and A. Ben-Amotz. 2000. Reduction of exercise-induced asthma oxidative stress by lycopene, a natural antioxidant. Allergy 55:1184.
38. Laurent, T. C., E. C. Moore, and P. Reichard. 1964. Enzymatic synthesis of deoxyribonucleotides. IV. Isolation and characterization of thioredoxin, the hydrogen donor from Escherichia coli B. J. Biol. Chem. 239:3426.
39. Jin, D. Y., H. Z. Chae, S. G. Rhee, and K. T. Jeang. 1997. Regulatory role for a novel human thioredoxin peroxidase in NF-κB activation. J. Biol. Chem. 272:30952.
40. Okamoto, T., H. Ogiwara, T. Hayashi, A. Mitsui, T. Kawabe, and J. Yodoi. 1992. Human thioredoxin/adult T cell leukemia-derived factor activates the enhancer binding protein of human immunodeficiency virus type 1 by thiol redox control mechanism. Int. Immunol. 4:811.
41. Kurooka, H., K. Kato, S. Minoguchi, Y. Takahashi, J. Ikeda, S. Habu, N. Osawa. A. M. Buchberg, K. Moriwaki, H. Shisa, and T. Honjo. 1997. Cloning and characterization of the nucleoredoxin gene that encodes a novel nuclear protein related to thioredoxin. Genomics 39:331.
42. Miranda-Vizuete, A., J. A. Gustafsson, and G. Spyrou. 1998. Molecular cloning and expression of a cDNA encoding a human thioredoxin-like protein. Biochem. Biophys. Res. Commun. 243:284.
43. Xanthoudakis, S., and T. Curran. 1992. Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. EMBO J. 11:653.
44. Hirota, K., M. Matsui, S. Iwata, A. Nishiyama, K. Mori, and J. Yodoi. 1997. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc. Natl. Acad. Sci. USA 94:3633.
45. Qin, J., G. M. Clore, W. P. Kennedy, J. Kuszewski, and A. M. Gronenborn. 1996. The solution structure of human thioredoxin complexed with its target from Ref-1 reveals peptide chain reversal. Structure 4:613.
46. Qin, J., G. M. Clore, W. M. Kennedy, J. R. Huth, and A. M. Gronenborn. 1995. Solution structure of human thioredoxin in a mixed disulfide intermediate complex with its target peptide from the transcription factor NF-κB. Structure 3:289.
47. Muller, C. W., F. A. Rey, M. Sodeoka, G. L. Verdine, and S. C. Harrison. 1995. Structure of the NF-κB p50 homodimer bound to DNA. Nature 373:311.
48. Ghosh, G., G. van Duyne, S. Ghosh, and P. B. Sigler. 1995. Structure of NF-κB p50 homodimer bound to a κB site. Nature 373:303.
49. Donovan, C. E., D. A. Mark, H. Z. He, H. C. Liou, L. Kobzik, Y. Wang, G. T. De Sanctis, D. L. Perkins, and P. W. Finn. 1999. NF-κB/Rel transcription factors: c-Rel promotes airway hyperresponsiveness and allergic pulmonary inflammation. J. Immunol. 163:6827
50. Das, J., C. H. Chen, L. Yang, L. Cohn, P. Ray, and A. Ray. 2001. A critical role for NF-κB in GATA-3 expression and Th2 differentiation in allergic airway inflammation. Nat. Immunol. 2:45.
51. Barnes, P. J. 1995. Inhaled glucocorticoids for asthma. N. Engl. J. Med. 332:868.
52. Adcock, I. M., and G. Caramori. 2001. Cross-talk between pro-inflammatory transcription factors and glucocorticoids. Immunol. Cell Biol. 79:376.
53. Covar, R. A., D. Y. Leung, D. McCormick, J. Steelman, P. Zeitler, and J. D. Spahn. 2000. Risk factors associated with glucocorticoid-induced adverse effects in children with severe asthma. J. Allergy Clin. Immunol. 106:651.
54. Adcock. I. M. 1996. Steroid resistance in asthma: Molecular mechanisms Am. J. Respir. Crit. Care Med. 154:S58-S61.